Get started
Author

Jeroen H. A. Creemers

Observed names: Creemers, J.H.A., Creemers, Jeroen, J. Creemers, J.H.A. Creemers, Jeroen H A Creemers, Jeroen H.A. Creemers
ORCID: 0000-0003-0371-8416
Observed ORCID: 0000-0003-0371-8416
OpenAlex ID: A5014410290
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
2019 · Harm Westdorp, Jeroen H. A. Creemers, et al. · Journal for ImmunoTherapy of Cancer · 116
PDF
Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
2015 · Kalijn F Bol, Erik H J G Aarntzen, et al. · OncoImmunology · 71
PDF
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial
2024 · Kalijn F. Bol, Gerty Schreibelt, et al. · Nature Communications · 63
PDF
Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol
2021 · Jeroen H A Creemers, Inka Pawlitzky, et al. · BMJ Open · 57
PDF
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
2022 · Lieke L van der Woude, Mark A J Gorris, et al. · Journal for ImmunoTherapy of Cancer · 46
PDF
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome
2023 · Jeroen H. A. Creemers, Ankur Ankan, et al. · Nature Communications · 43
PDF
PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses
2021 · Yusuf Dölen, Uzi Gileadi, et al. · Frontiers in Immunology · 38
PDF
Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients
2016 · Steve Boudewijns, Harm Westdorp, et al. · Journal of Immunotherapy · 34
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery
2021 · Jeroen H.A. Creemers, W. Joost Lesterhuis, et al. · Journal for ImmunoTherapy of Cancer · 28
PDF
Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
2021 · J.H.A. Creemers, M.J. van der Doelen, et al. · Frontiers in Oncology · 17
PDF
Leveraging mathematical models to improve the statistical robustness of cancer immunotherapy trials
2025 · Jeroen H.A. Creemers, Johannes Textor · Current Opinion in Systems Biology · 9
High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
2020 · Harm Westdorp, Jeroen H. A. Creemers, et al. · Frontiers in Oncology · 5
PDF
Phenol Neurolysis in Pain and Palliative Medicine
2026 · Jeroen H. A. Creemers, Rachel J. H. Smits, et al. · Pain Practice · 3
Natural dendritic cell vaccinations generate immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
2019 · J. Creemers, H. Westdorp, et al. · Annals of Oncology · 3
Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.
2018 · Harm Westdorp, Inge M. van Oort, et al. · Journal of Clinical Oncology · 2
MOESM3 of Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
2019 · Westdorp, Harm, Creemers, Jeroen, et al. · Figshare
MOESM2 of Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
2019 · Westdorp, Harm, Creemers, Jeroen, et al. · Figshare
MOESM5 of Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
2019 · Westdorp, Harm, Creemers, Jeroen, et al. · Figshare
Works count: 25
Citation count: 535
H-index: 10
I10-index: 10
Year
Topic
Type